Betrion 20 mg/g mazilo Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

betrion 20 mg/g mazilo

pliva ljubljana d.o.o., ljubljana - mupirocin - mazilo - mupirocin 20 mg / 1 g - mupirocin

Edion 100 mg trde kapsule Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

edion 100 mg trde kapsule

kapsula, trda - gabapentin

Edion 400 mg trde kapsule Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

edion 400 mg trde kapsule

kapsula, trda - gabapentin

Edion 300 mg trde kapsule Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

edion 300 mg trde kapsule

kapsula, trda - gabapentin

Distraneurin 192 mg mehke kapsule Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

distraneurin 192 mg mehke kapsule

cheplapharm arzneimittel gmbh - klometiazol - kapsula, mehka - klometiazol 192 mg / 1 kapsula - klometiazol

NOVANTRONE 2 mg/ml koncentrat za raztopino za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

novantrone 2 mg/ml koncentrat za raztopino za injiciranje/infundiranje

meda pharma gmbh & co. kg - mitoksantron - koncentrat za raztopino za injiciranje/infundiranje - mitoksantron 20 mg / 1 ml - mitoksantron

Nevanac Evropska unija - slovenščina - EMA (European Medicines Agency)

nevanac

novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - oftalmologi - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Onglyza Evropska unija - slovenščina - EMA (European Medicines Agency)

onglyza

astrazeneca ab - saxagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Opatanol Evropska unija - slovenščina - EMA (European Medicines Agency)

opatanol

novartis europharm limited - olopatadinijev klorid - konjunktivitis, alergični - oftalmologi - zdravljenje očesnih znakov in simptomov sezonskega alergijskega konjunktivitisa.

Travatan Evropska unija - slovenščina - EMA (European Medicines Agency)

travatan

novartis europharm limited - travoprost - glaucoma, open-angle; ocular hypertension - oftalmologi - zmanjšanje zvišanega očesnega tlaka pri odraslih bolnikih z očesno hipertenzijo ali glavkomom odprtega zakotja (glejte poglavje 5. znižanje zvišanega očesnega tlaka pri pediatričnih bolnikih, starih od 2 mesecev do < 18 let, s očesni hipertenzije ali pediatričnih glavkoma (glej poglavje 5.